J&J says kept drug price increases below 10 pct since 2012
February 27, 2017 at 14:28 PM EST
NEW YORK, Feb 27 (Reuters) - Johnson & Johnson on Monday said the average list price of its drugs rose less than 10 percent each year since 2012, noting that the net price paid for the drugs, which includes discounts and rebates, was significantly lower.